GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...

Berenberg Bank analyst Kerry Holford maintained a Hold rating on Hochschild Mining (HOC – Research Report) yesterday and set a price target of ...

Ischemic stroke market Insights: Rising prevalence of ischemic strokes boosts demand for effective treatment and prevention strategies.

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals ... Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

Ana Botin, executive chair of Spanish bank Santander has denied reports that the company is considering leaving the British ...

Analysts predict the home care segment to grow at 5 per cent (Y-o-Y/Q-o-Q?), Beauty and Personal Care (BPC) at 3 per cent, and food at 2 per cent. They expect a decline of 31 bps Y-o-Y in Ebitda ...

About GSK GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.